Vivo Bio Tech Ltd

Know More
NSEBSE
Stock not tradded

33.25-0.17 (-0.51%)

04:01 PM,1st Dec 2023

BSE : 511509

NSE :

Sector : Health care

ISIN Code : INE380K01017

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Dec 01 2023 | 04:01 PM IST

Market Cap (₹ Cr)

0

Turnover (₹ Cr)

0.00

Volume (Shares)

Face Value

10

52-WK High

0.00

52-WK High Date

Invalid date

52-WK Low

0.00

52-WK Low Date

Invalid date

All Time High

0.00

All Time High Date

Invalid date

All Time Low

0.00

All Time Low Date

Invalid date

Vivo Bio Tech Ltd

Vivo Bio Tech is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD AAALAC & IND guidelines. The company offers services in the areas of In vitro In vivo toxicity studies pharmacological investigations pharmacokinetics & toxicokinetic studies etc. Our experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. Tailored and dedicated to our clients we distinguish your development plan is as superlative as the products you bring to our testing facilities.The Biologic Research Services group at Vivo Bio Tech offers a complete line of protein services including gene synthesis cloning expression and purification of recombinant proteins and monoclonal antibodies. Our scientists will team up with you to develop solution for the most difficult to deal products including purification of untagged & poorly expressed proteins.In-vitro Services offers solutions for pharmacologic toxicological & bioanalytical investigations in drug discovery & development. Critical investigations like bacterial reverse mutation assays chromosomal aberration and micronucleus are specialty services by our scientists.The In-vivo Services group at Vivo Bio Tech provides both non-regulatory and regulatory IND enabling preclinical development services. We are capable of screening & evaluating molecules for various pharmacological & therapeutic properties. Specifically for oncology our scientists can provide design & development of xenograft models for evaluation of anti-cancer agents. Further our scientists can customize in-vivo DMPK studies to help profile your drug candidate in both rodent and non-rodent animal models.Vivo Bio has partnered with Taconic for sourcing foundation and expansion colonies of the animal models and have started in-house breeding of Specific Pathogen Free rodents.

Vivo Bio Tech Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

49

EPS - TTM (₹) [S]

1.81

P/E Ratio (X) [S]

0.95

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [S]35.14
P/B Ratio (₹) [S]0.95
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

30.75

33.88

Week Low/High

30.75

34.00

Month Low/High

30.75

37.00

Year Low/High

18.11

39.00

All time Low/High

1.05

115.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-0.75%%2.292.39%
1 Month-3.65%%6.126.73%
3 Month17.49%%3.204.28%
6 Month6.78%%8.099.63%
1 Year-7.38%%6.637.74%
3 Year-31.65%%51.1254.61%

Company Info

Company Information

Whole-time Director : Kalyan Ram Mangipudi

Whole-time Director : Alangudi Sankaranarayanan

Chairman & Independent Directo : K Sunder

Independent Director : Hariharan Ravindran

Independent Director : Kunda Kalpana

Director : Karopadi Shivanand Nayak

Whole Time Director & CFO : K Sri Kalyan

Additional Director : Shyam Sunder Tipparaju

Registered Office: Survey #349/A Pregnapur Vlge, ,Gajel,Telangana-502311 Ph:

Email:investors@vivobio.com

URL:http://www.vivobio.com